Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-<i>a</i>]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies
A series of ethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-<i>a</i>]quinoline-3-carboxylates <b>4a</b>-<b>f</b> and dimethyl 1-(substituted benzoyl)-5-methylpyrrolo[1,2-<i>a</i>]quinoline-2,3-dicarboxylates <b>4g</b>-<b>k</b>...
Saved in:
Main Authors: | Katharigatta N. Venugopala (Author), Vijayakumar Uppar (Author), Sandeep Chandrashekharappa (Author), Hassan H. Abdallah (Author), Melendhran Pillay (Author), Pran Kishore Deb (Author), Mohamed A. Morsy (Author), Bandar E. Aldhubiab (Author), Mahesh Attimarad (Author), Anroop B. Nair (Author), Nagaraja Sreeharsha (Author), Christophe Tratrat (Author), Abdulmuttaleb Yousef Jaber (Author), Rashmi Venugopala (Author), Raghu Prasad Mailavaram (Author), Bilal A. Al-Jaidi (Author), Mahmoud Kandeel (Author), Michelyne Haroun (Author), Basavaraj Padmashali (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
by: Katharigatta N. Venugopala, et al.
Published: (2021) -
Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives
by: Katharigatta N. Venugopala, et al.
Published: (2022) -
5-Benzyliden-2-(5-methylthiazol-2-ylimino)thiazolidin-4-ones as Antimicrobial Agents. Design, Synthesis, Biological Evaluation and Molecular Docking Studies
by: Michelyne Haroun, et al.
Published: (2021) -
Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4<i>H</i>-1,2,4-Triazole-3-Thiol and Its Schiff Bases: Computational Input and Molecular Dynamics
by: Katharigatta N. Venugopala, et al.
Published: (2020) -
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis
by: Pran Kishore Deb, et al.
Published: (2021)